Tina L. Mistry

Benzimidazole-Based FabI Inhibitors: A Promising Novel Scaffold for Anti-staphylococcal Drug Development

Tina L. Mistry, Lena Truong, Arun K. Ghosh et al. · ACS Infectious Diseases · 2016 · 34 citations · Full text

Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI)

Shahila Mehboob, Jinhua Song, Kirk E. Hevener et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 22 citations · Full text

Benzimidazole Inhibitors, Biosynthesis, Novel Series +13

A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii

Ji-Eun Kwon, Tina L. Mistry, Jinhong Ren et al. · Bioorganic & Medicinal Chemistry · 2017 · 20 citations · Full text

Inhibitory Activity, Health Sciences, Enoyl Reductase Inhibitors +12

Determination of absolute configuration and binding efficacy of benzimidazole-based FabI inhibitors through the support of electronic circular dichroism and MM-GBSA techniques

Jinhong Ren, Tina L. Mistry, Pin‐Chih Su et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 10 citations · Full text

Benzimidazole-based Fabi Inhibitors, Medicinal Chemistry, Drug Target +12